Yi-chen Liang
发表
S. Zhang,
Gang Wu,
Liangliang Shi,
2013,
PloS one.
Gang Wu,
Jing Chen,
Yu Chang,
2015,
OncoTargets and therapy.
Gang Wu,
Liangliang Shi,
Tao Liu,
2013,
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
S. Zhang,
Gang Wu,
Hong Ma,
2014,
Scientific Reports.
Tao Zhang,
Sheng Chen,
Dandan Yu,
2014,
European journal of ophthalmology.
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation
Yung-Chun Chang,
Jing Chen,
Jinghua Ren,
2015
.
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation
Yung-Chun Chang,
Jing Chen,
Jinghua Ren,
2015
.
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation
Yung-Chun Chang,
Jing Chen,
Jinghua Ren,
2015
.
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation
Yung-Chun Chang,
Jing Chen,
Jinghua Ren,
2015
.